MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Opioid Use Disorder
Interventions
OTHER

MySafeRx

The MySafeRx platform is a combination of several key components, including daily videoconferencing check-ins with motivational interviewing-based recovery coaching, text-messaging reminders, secure storage of buprenorphine medication within a secure electronic pill dispenser (i.e., MedicaSafe 3000), and a standardized protocol for supervising self-administration of medication via videoconferencing.

Trial Locations (1)

02139

Cambridge Health Alliance, Cambridge

All Listed Sponsors
collaborator

MedicaSafe, Inc.

INDUSTRY

collaborator

MySafeRx, Inc

UNKNOWN

collaborator

Dartmouth College

OTHER

lead

Cambridge Health Alliance

OTHER

NCT02942199 - MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE) | Biotech Hunter | Biotech Hunter